Early treatment study
et al., medRxiv, doi:10.1101/2020.08.16.20175752 (Preprint) (not included in the study count)
Hydroxych loroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia
Safety study of 2,733 patients in Saudi Arabia showing HC Q in mild to moderate cases in an outpatient setting, within the protocol recommendation and inclusion/exclusion criteria, is safe, highly tolerable, and has minimal side effects. No ICU admission or deaths were reported.
Please send us corrections, updates, or comments.